A Dose-escalation, Dose-extension and Efficacy-extension, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Preliminary Efficacy of AP-L1898 Capsule for the Treatment of the Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
Latest Information Update: 27 Oct 2022
At a glance
- Drugs JS 111 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; First in man; Therapeutic Use
- 12 Aug 2021 New trial record